Email this article 
Hide
Show all
Original Research
Integrated vs non-integrated treatment outcomes in dual diagnosis disorders: A systematic review
Submitted: 24 June 2022 | Published: 25 April 2023
About the author(s)
Ashley Chetty, Department of Psychology, Faculty of Humanities, University of Pretoria, Pretoria, South AfricaTharina Guse, Department of Psychology, Faculty of Humanities, University of Pretoria, Pretoria, South Africa
Mosa Malema, Department of Psychology, Faculty of Humanities, University of Pretoria, Pretoria, South Africa
Abstract
Background: The incidence of dual diagnosis (DD) (i.e. substance use disorders [SUD] and co-occurring mental disorders) is widespread; however, they vary widely in permutation and combination. As a result, establishing effective and empirically supported interventions for this clinical population remains challenging.
Aim: This study aimed to examine current literature on the treatment outcomes for patients with DD.
Method: A systematic review of randomised controlled trials (RCTs) published between 2009 and 2018 was conducted for two broad intervention categories identified by the literature: non-integrated and integrated treatment. Multiple electronic databases were searched using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA).
Results: The search generated a total of 743 studies, of which 11 satisfied the inclusion criteria. These studies were thematically synthesised into two main analytical themes: ‘treatment outcomes’ and ‘reported strengths and limitations of DD treatment’. Specifically, integrated treatment held an advantage over non-integrated treatment in significantly improving psychiatric symptomatology. However, no significant benefits were found between integrated and non-integrated treatment regarding substance misuse and treatment retention.
Conclusion: Overall, the results provided insufficient evidence to support the enhanced efficacy of integrated or non-integrated treatment over the other in treating patients with DD.
Contribution: The study’s findings were used to provide recommendations to inform the clinical psychological service delivery of dual diagnosis treatment in South Africa and also to identify gaps in the literature and highlight areas for future research.
Keywords
Metrics
Total abstract views: 5087Total article views: 4204
Crossref Citations
1. Anxiety and depression among a community‐recruited cohort of people who use methamphetamine: A longitudinal analysis
Zoe Duncan, Rebecca Kippen, Keith Sutton, Bernadette Ward, Kasun Rathnayake, Brendan Quinn, Paul Dietze
Addiction vol: 120 issue: 4 first page: 697 year: 2025
doi: 10.1111/add.16714
2. Nurses' Perceptions of Patients With Co‐Occurring Psychiatric and Substance Use Disorders in Psychiatric Settings: A Grounded Theory Study
Etienne Bertrand, Jean‐Manuel Morvillers
Journal of Advanced Nursing vol: 81 issue: 9 first page: 6022 year: 2025
doi: 10.1111/jan.16748
3. Time to integrated care and social and clinical determinants: secondary analysis of a multicenter study in persons with dual diagnosis
Diptadhi Mukherjee, Abhishek Ghosh, Tathagata Mahintamani, Sourav Khanra, Sambhu Prasad, Anirudha Basu, Susanta Padhy, Navratan Suthar, Aditya Somani, Sidharth Arya, Basudeb Das, Pankaj Kumar, Kumari Rina, Rebecca Haokip, Aparajita Guin, Shree Mishra, Naresh Nebhinani Nebhinani, Lokesh Kumar Singh, Rajiv Gupta, Debasish Basu
Advances in Dual Diagnosis vol: 18 issue: 3 first page: 126 year: 2025
doi: 10.1108/ADD-02-2025-0007
4. Predictors of engagement and dropout in the context of joint treatment for dual disorders: An exploratory analysis
Andrea Saverio Spagnuolo, Ottone Baccaredda Boy, Ilaria Noschese, Niccolò Porcinai, Ferdinando Elia, Giovanni Castellini, Francesco Rotella, Valdo Ricca, Cecilia Lanzi, Brunella Occupati, Icro Maremmani, Guido Mannaioni, Andrea Ballerini
Heroin Addiction and Related Clinical Problems vol: 27 issue: 1 first page: 1 year: 2025
doi: 10.62401/2531-4122-2025-22
5. Making meaning of co-occurring psychosis and addiction: a hermeneutic phenomenological study of NHS practitioners’ lived experience
Andrew Seed, Amy Fisher, Barbara Murvai, Bennett Alakakone, Paul Barber, Francine Fowler
Psychodynamic Practice first page: 1 year: 2025
doi: 10.1080/14753634.2025.2583931
6. Comprehensive Review on Association of Bipolar Disorder and Substance Abuse: Dual Diagnosis and Treatment Approaches
Felicia T Bonner-Reid, Arzoo Dar, Annu Zerin, Anushka Prakash Mishra, Claudia Lollobattista, Niketa Narasimhan, Smit Desai, Satneet Singh
Cureus year: 2025
doi: 10.7759/cureus.86363
7. Effectiveness of Psychosocial Interventions for Adults With Substance Use Disorder That Have a Co‐Occurring Common Mental Health Disorder: An Umbrella Review
Emma L. Simpson, Munira Essat, Ruth Wong, Sarah Stacey, Edward Day
Drug and Alcohol Review vol: 45 issue: 1 year: 2026
doi: 10.1111/dar.70066
8. Coordinated Treatment for Dual Diagnosis: Longer Treatment with Comparable Outcomes to Substance Use Disorder-Only Outpatients
Óscar M. Lozano, Marta Narváez-Camargo, Daniel Dacosta-Sánchez, Cinta Mancheño-Velasco
Substance Use & Misuse vol: 60 issue: 10 first page: 1514 year: 2025
doi: 10.1080/10826084.2025.2505761
9. Non-Pharmacological Components in Integrated Treatment for Patients with Dual Diagnosis: A Scoping Review
Signe Wegmann Düring, Ditte Maria Sivertsen, Katrine Schepelern Johansen
Journal of Dual Diagnosis vol: 21 issue: 2 first page: 120 year: 2025
doi: 10.1080/15504263.2025.2478900
10. Provider Perspectives on Medication for AUD in Mental Health and Substance Use Disorder Clinics
Corinne N. Kacmarek, Julie Kreyenbuhl, Hildi J. Hagedorn, Clayton H. Brown, Elizabeth Jane Richardson, Max Spaderna, Madeline R. Marks, Melanie E. Bennett, Daniel J. O. Roche
Journal of Dual Diagnosis vol: 21 issue: 3 first page: 224 year: 2025
doi: 10.1080/15504263.2025.2515026
11. Concurrent Disorders and Treatment Outcomes: A Meta-Analysis
Kathryn Danielle Scott, Kevin Michael Gorey
Journal of Dual Diagnosis vol: 21 issue: 3 first page: 251 year: 2025
doi: 10.1080/15504263.2025.2515015